ARCHIVES

Insurer Declines To Cover Avastin For Breast Cancer, Institutes Review Procedure For Exceptional Cases

This article is from The Cancer Letter archive.

Vol. 37 No. 39 | October 21, 2011

Download PDF Visit The Full Archive

Related Articles

M.D. Anderson Stops Establishing Satellite Clinics, Views Role as Working With All Texas Oncologists

November 22, 1996

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

Protein May Link Obesity To Cancer Aggressiveness

February 22, 2013

Only Seven Of 66 “Benign” Breast Cancer Turn Out to Be Doubtful

November 25, 1977

NCI Advisors Approve New Grant Programs Worth $100 Million

March 27, 2009